[Federal Register Volume 87, Number 32 (Wednesday, February 16, 2022)]
[Notices]
[Pages 8845-8846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03257]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

Docket No. FDA-2018-N-3233]


Request for Nominations on the Technical Electronic Product 
Radiation Safety Standards Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is requesting 
that any industry organizations interested in participating in the 
selection of voting industry representatives to serve on the Technical 
Electronic Product Radiation Safety Standards Committee in the Center 
for Devices and Radiological Health notify FDA in writing. FDA is also 
requesting nominations for voting industry representatives to serve on 
the Technical Electronic Product Radiation Safety Standards Committee. 
A nominee may either be self-nominated or nominated by an organization 
to serve as a voting industry representative. Nominations will be 
accepted for current vacancies effective with this notice.

DATES: Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests must send a letter stating that interest to FDA by March 18, 
2022 (see sections I and II of this document for further details). 
Concurrently, nomination materials for prospective candidates should be 
sent to FDA by March 18, 2022.

ADDRESSES: All statements of interest from industry organizations 
interested in participating in the selection process of voting industry 
representative nominations should be sent to Margaret Ames (see FOR 
FURTHER INFORMATION CONTACT). All nominations for voting industry 
representatives should be submitted electronically by accessing the FDA 
Advisory Committee Membership Nomination Portal: https://www.accessdata.fda.gov/scripts/FACTRSPortal/FACTRS/index.cfm or by mail 
to Advisory Committee Oversight and Management Staff, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver 
Spring, MD 20993-0002. Information about becoming a member of an FDA 
advisory committee can also be obtained by visiting FDA's website at 
https://www.fda.gov/AdvisoryCommittees/default.htm.

FOR FURTHER INFORMATION CONTACT: Margaret Ames, Division of Management 
Services, Center for Devices and Radiological Health, Food and Drug 
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5213, Silver 
Spring, MD 20993, 301-796-5960, email: <a href="/cdn-cgi/l/email-protection#4c012d3e2b2d3e2938620d21293f0c2a282d6224243f622b233a"><span class="__cf_email__" data-cfemail="d29fb3a0b5b3a0b7a6fc93bfb7a192b4b6b3fcbabaa1fcb5bda4">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: The Agency is requesting nominations for 
voting industry representatives on the Technical Electronic Product 
Radiation Safety Standards Committee:

I. General Description of the Committee Duties

    This Committee provides advice and consultation to the Commissioner 
of Food and Drugs (the Commissioner) on the technical feasibility, 
reasonableness, and practicability of performance standards for 
electronic products to control the emission of radiation from such 
products and may recommend electronic product radiation safety 
standards to the Commissioner for consideration.

II. Selection Procedure

    Any industry organization interested in participating in the 
selection of an appropriate voting member to represent industry 
interests should send a letter stating that interest to the FDA contact 
(see FOR FURTHER INFORMATION CONTACT) within 30 days of publication of 
this document (see DATES). Within the

[[Page 8846]]

subsequent 30 days, FDA will send a letter to each organization that 
has expressed an interest, attaching a complete list of all such 
organizations, and a list of all nominees along with their current 
r[eacute]sum[eacute]s. The letter will also state that it is the 
responsibility of the interested organizations to confer with one 
another and to select a candidate, within 60 days after the receipt of 
the FDA letter, to serve as the voting member to represent industry 
interests for the committee. The interested organizations are not bound 
by the list of nominees in selecting a candidate. However, if no 
individual is selected within 60 days, the Commissioner will select the 
voting member to represent industry interests.

III. Nomination Procedure

    Individuals may self-nominate and/or an organization may nominate 
one or more individuals to serve as a voting industry representative. 
Nominations must include a current, complete r[eacute]sum[eacute] or 
curriculum vitae for each nominee including current business address 
and telephone number, email address if available, and a signed copy of 
the Acknowledgement and Consent form available at the FDA Advisory 
Nomination Portal (see ADDRESSES). Nominations must also specify the 
advisory committee for which the nominee is recommended. Nominations 
must also acknowledge that the nominee is aware of the nomination 
unless self-nominated. FDA will forward all nominations to the 
organizations expressing interest in participating in the selection 
process for the committee. (Persons who nominate themselves as voting 
industry representatives will not participate in the selection 
process.)
    FDA seeks to include the views of women and men, members of all 
racial and ethnic groups, and individuals with and without disabilities 
on its advisory committees and therefore encourages nominations of 
appropriately qualified candidates from these groups.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: February 10, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022-03257 Filed 2-15-22; 8:45 am]
BILLING CODE 4164-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>